Michael Kim, MD
Radiation Oncology · Baltimore, MDNPI 1841979333
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (51.7%), travel and lodging and gifts — rather than concentrated in one kind of arrangement. Bioprotect Medical, Inc. accounts for 66.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,592, more than ten times the $117 reported in 2023.
Across 18 payments — averaging $129.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioprotect Medical, Inc.$2K
- Boston Scientific$276
- Teleflex LLC$152
- Sumitomo Pharma America, Inc.$133
- KARL Storz Endoscopy-america$89
- Ultradent Products Inc$67
- plus $53 from 2 others
What the payments were for
- Travel & lodging$1,05945%
- Food & beverage$1,20652%
- Gifts$673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioprotect Medical, Inc. | 7 | $1,562 |
| Boston Scientific | 4 | $276 |
| Teleflex LLC | 2 | $152 |
| Sumitomo Pharma America, Inc. | 1 | $133 |
| KARL Storz Endoscopy-america | 1 | $89 |
| Ultradent Products Inc | 1 | $67 |
| Civco Medical Instruments | 1 | $27 |
| Progenics Pharmaceuticals, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,333 in reported general payments places this provider in the 70th percentile of 108 radiation oncology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Baltimore
- Sahaja AcharyaBaltimore$200K
- Arpit ChhabraBaltimore$97K
- Lawrence KleinbergBaltimore$34K
- Danny SongBaltimore$32K
- Jason MolitorisBaltimore$26K
- Kristin RedmondBaltimore$17K
- Avani RaoBaltimore$10K
- Amanda WalkerBaltimore$9K
- Christopher JohnsonBaltimore$7K
- Russell HalesBaltimore$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.